"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
In this interview, News Med talks to Lisa Cratty about the unpredictable lab environment and
The baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus
expression vector system (BEVS)— remains a crucial technology for manufacturing large and complex
proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product
design, and versatility for a broad range of proteins.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro about his research, as well as the role of compound management in pharmaceutical research.
In this new podcast, Bruker's Kate Stumpo talks with Enveda's Pelle Simpson on the opportunities of natural products in the field of multiomics.
In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.
In this interview, AZoNetwork speaks with Joe Barco, the Senior Director of Workflow Marketing at Unchained Labs, about the benefits of automated buffer exchange with Big Tuna.
In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.
In this interview, NewsMedical speaks with Richard Edridge, Synbiosis Projects and Sales Manager for Synoptics, about AutoCOL, a completely automated colony counting system for fully traceable colony counts with every use.
In this interview, Master Bond describes the features and benefits of medical grade adhesives for medical device manufacturing.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Garry Pairaudeau, Chief Technology Officer at Exscientia, about pharmatech, AI, and more.
In this interview conducted in anticipation of ELRIG's Drug Discovery 2023 Conference, we spoke to Nick Clare, Vendor Strategy Work Group Lead for ELRIG, about what vendors can gain from attending ELRIG events, such as Drug Discovery 2023.
In this Interview, NewsMedical talks to Ben Krenke about the Spectrum CE system for Forensic laboratory workflow.
In this interview, we speak to Mariana Leal, Team Lead at Owlstone Medical, about breath biopsies and how they are a useful tool for investigating biomarkers for the early detection of diseases.
In this interview, Istvan Szatmari, the Head of The Genomic Core Facility at the Department of Biochemistry and Molecular Biology, talks to NewsMed about the evolution of Molecular Biology.
In this interview, Rizwana Mia, the Senior Program Manager at South African Medical Research Council, talks to News Medical about the African personalized medicine agenda.
In this interview, Davide Cacchiarelli, Molecular Biology and Genomics Professor at the University of Naples talks to NewsMed about how the COVID pandemic has highlighted the vital role of genomic surveillance and improved genomics.
In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.
In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about
current developments in the field of vaccine development through recombinant techniques.
In this interview, NewsMedical talks to Jason Otterstrom about the role of AI-based Athena Zebrafish software in exploring Zebrafish imaging results and its importance for bio-medical research using Zebrafish models.
In this episode of omg OMx, Bruker's science-driven podcast, Kate Stumpo interviews Daniel Hornburg, the VP of Proteomics at Seer, as they discuss the innovative technologies in plasma proteomics. From nanoparticle-based enrichment to mass spec refinements, they explore how these tools facilitate unbiased, deep, and rapid proteomics.